Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-28T13:33:58.226Z Has data issue: false hasContentIssue false

98 - Netupitant/Palonosetron

Published online by Cambridge University Press:  06 October 2020

Stephen D. Silberstein
Affiliation:
Thomas Jefferson University, Philadelphia
Michael J. Marmura
Affiliation:
Thomas Jefferson University, Philadelphia
Hsiangkuo Yuan
Affiliation:
Thomas Jefferson University, Philadelphia
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

THERAPEUTICS

Brands

• Akynzeo

Generic?

• No

Class

• Antiemetic

Commonly Prescribed for

(FDA approved in bold)

Prevention of chemotherapy-induced nausea and vomiting (CINV)

• Nausea and vomiting (gastroenteritis, postoperative)

• Pruritus

How the Drug Works

• Netupitant: selectively inhibits substance P (vomit inducer) at neurokinin 1 (NK1) receptors with long-lasting brain receptor (brainstem, area postrema) saturation after single dose

• Palonosetron: second-generation 5-HT3 antagonist with higher binding affinity and longer plasma half-life. It may trigger 5-HT3 receptor internalization and prolong receptor inhibition

How Long Until It Works

• Typically less than an hour

If It Works

• Use at lowest effective dose

If It Doesn't Work

• Increase dose, or discontinue and change to another agent

Best Augmenting Combos for Partial Response or Treatment-Resistance

• May add D2 antagonist, antihistamine, benzodiazepine, or corticosteroid

Tests

• None required

ADVERSE EFFECTS (AEs)

How the Drug Causes AEs

• Not known

Notable AEs

• Headache, asthenia, dyspepsia, fatigue, constipation, and erythema

Life-Threatening or Dangerous AEs

• Serotonin syndrome

• Hypersensitivity reactions such as angioedema and Stevens-Johnson syndrome have been reported

Weight Gain

• Unusua

Sedation

• Unusual

What to Do About AEs

• Reduce dose or discontinuation

Best Augmenting Agents to Reduce AEs

• Symptomatic management

DOSING AND USE

Usual Dosage Range

• 1 capsule

Dosage Forms

• Capsule: 300mg netupitant and 0.5mg palonosetron

How to Dose

• One capsule 1 hour and dexamethasone 12mg 30 minutes prior to chemotherapy on day 1. Dexamethasone 8mg orally once daily on days 2 to 4 if under highly emetogenic chemotherapy (cisplatin)

Dosing Tips

• Can be taken with or without food. Only for short-term use

Overdose

• May develop drowsiness or headache

Long-Term Use

• Not been studied

Habit Forming

• No

How to Stop

• No need to taper

Pharmacokinetics

• Netupitant: Tmax: 5 hours. Half-life: 80 hours. > 99.5% protein bound. Metabolized by CYP3A4 and inhibits CYP3A4

Type
Chapter
Information
Essential Neuropharmacology
The Prescriber's Guide
, pp. 360 - 362
Publisher: Cambridge University Press
Print publication year: 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×